X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-16 | QURE | Potts Jeannette | GC | S - Sale | $15.14 | -4,670 | 115,073 | -4% | -$70,704 | ||||||
| D | 2025-03-04 | QURE | Kapusta Matthew C | CEO, MD | S - Sale+OE | $10.29 | -28,341 | 651,454 | -4% | -$291,629 | |||||
| D | 2025-03-04 | QURE | Abi-Saab Walid | Chief Medical Officer | S - Sale+OE | $10.29 | -1,350 | 151,903 | -1% | -$13,892 | |||||
| D | 2025-03-04 | QURE | Klemt Christian | CFO | S - Sale+OE | $10.29 | -10,438 | 217,730 | -5% | -$107,407 | |||||
| D | 2025-03-04 | QURE | Potts Jeannette | GC | S - Sale+OE | $10.29 | -7,076 | 119,743 | -6% | -$72,812 | |||||
| M | 2025-02-25 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $10.82 | -33,444 | 580,795 | -5% | -$362,015 | |||||
| M | 2025-02-25 | QURE | Klemt Christian | CFO | S - Sale | $10.80 | -17,257 | 155,168 | -10% | -$186,458 | |||||
| D | 2024-12-10 | QURE | Kapusta Matthew C | CEO, MD | S - Sale+OE | $15.03 | -100,000 | 597,915 | -14% | -$1,503,000 | |||||
2024-12-09 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $7.63 | -3,418 | 597,915 | -1% | -$26,079 | ||||||
2024-12-09 | QURE | Klemt Christian | CFO | S - Sale | $7.55 | -1,796 | 166,713 | -1% | -$13,560 | ||||||
2024-06-26 | QURE | Abi-Saab Walid | Chief Medical Officer | S - Sale | $4.36 | -1,447 | 115,253 | -1% | -$6,309 | ||||||
2024-06-17 | QURE | Caloz Pierre | COO | S - Sale | $4.81 | -2,936 | 115,707 | -2% | -$14,122 | ||||||
2024-06-17 | QURE | Klemt Christian | CFO | S - Sale | $4.80 | -1,611 | 164,837 | -1% | -$7,733 | ||||||
2024-06-13 | QURE | Post Leonard E | Dir | S - Sale | $5.14 | -2,222 | 15,999 | -12% | -$11,421 | ||||||
2024-06-13 | QURE | Potts Jeannette | GC | S - Sale | $4.98 | -4,781 | 91,819 | -5% | -$23,809 | ||||||
2024-06-13 | QURE | Springhorn Jeremy P. | Dir | S - Sale | $5.12 | -2,231 | 23,756 | -9% | -$11,423 | ||||||
2024-06-13 | QURE | Meek David D. | Dir | S - Sale | $5.12 | -2,229 | 20,252 | -10% | -$11,412 | ||||||
2024-06-13 | QURE | Balachandran Madhavan | Dir | S - Sale | $5.12 | -2,231 | 23,759 | -9% | -$11,423 | ||||||
2024-06-13 | QURE | Soteropoulos Paula | Dir | S - Sale | $5.14 | -2,220 | 20,203 | -10% | -$11,411 | ||||||
2024-06-13 | QURE | Gut Robert | Dir | S - Sale | $5.12 | -3,504 | 44,165 | -7% | -$17,940 | ||||||
2024-06-13 | QURE | Kaye Jack | Dir | S - Sale | $5.16 | -2,218 | 6,501 | -25% | -$11,445 | ||||||
2024-06-13 | QURE | Jacques Rachelle Suzanne | Dir | S - Sale | $5.14 | -2,221 | 14,408 | -13% | -$11,416 | ||||||
2024-02-26 | QURE | Caloz Pierre | COO | S - Sale | $6.47 | -9,455 | 85,643 | -10% | -$61,174 | ||||||
2024-02-26 | QURE | Klemt Christian | CFO | S - Sale | $6.38 | -15,906 | 116,948 | -12% | -$101,480 | ||||||
2024-02-26 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $6.35 | -27,904 | 440,839 | -6% | -$177,190 | ||||||
2023-09-18 | QURE | Dolmetsch Ricardo | Pres, R, D | S - Sale | $7.46 | -5,841 | 163,404 | -3% | -$43,574 | ||||||
2023-07-10 | QURE | Caloz Pierre | COO | S - Sale | $11.36 | -15,117 | 95,098 | -14% | -$171,729 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |